Editor's Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards's insights will bring great value to the oncology community.
Professor and Chair, Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Liquid biopsies have been shown to be as good as tumor biopsies in analyzing gene mutations that can…
Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Rutgers-CINJ Associate Director, Clinical Research
Director Clinical Oncology Research, RWJ-B Health System
Congratulations to Dr von Mehren and her colleagues on a highly positive study of Ripretinib in refr…
Executive Director
Community Oncology Alliance
PBMs are getting more brazen in how they delay and deny cancer patients their oral drugs. Anyone in …
National Health Policy Expert
Payer Prior Authorization: Intrusion, Disruption and Patient Harm
Is it any surprise that the freq…
Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
Grover C. Bagby Chair of Prostate Cancer Research
OHSU Knight Cancer Institute Deputy Director, OHSU Knight Cancer Institute, School of Medicine
Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine
Cardiovascular complications are increased in patients treated with modern hormonal agents when comp…
Associate Clinical Professor, Medical Oncology
Executive Director, Employer Services
City of Hope Comprehensive Cancer Center
Duarte, CA
Disappointing but not surprising. Despite the recent press release about CheckMate 227 results show…
President, W-Squared Group
This piece is a great example of a pathway program in process. Clinical pathways are not meant to b…
Professor and Director, Division of Hematology Oncology
Department of Medicine,Cedars-Sinai Medical Center
Associate Director for Academic Program Development
Samuel Oschin Comprehensive Cancer Institute
Professor of Medicine and Urology, Emeritus
David Geffen School of Medicine at UCLA
This long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …
FACP FACPE FASCO
President, Minnesota Oncology
Including patient assistance funding provided by manufacturers directly to patients in ASP pricing w…
CEO
Tennessee Oncology
I found this article both fascinating and enlightening. I had not thought of "burnout" in terms of …
Vice President
Integrated Community Oncology Network
Former Community Representative
ASCO Board of Directors
COA absolutely has it right on this proposal. Mandatory participation in these proposed payment mod…
Florida Cancer Specialists
President and Managing Partner
Like the data…
Ronald H. Bloom Chair in Cancer Therapeutics
Professor and Chair, Department of Radiation Oncology
Interim Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Some of the leaders in the US from UCLA and UCSF report on their Ga68 PSMA PET scan results in prost…
Follow @OBRTweets